中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

遗传代谢性肝病的临床特征及诊断思路

彭姗姗 杨永峰

引用本文:
Citation:

遗传代谢性肝病的临床特征及诊断思路

DOI: 10.3969/j.issn.1001-5256.2019.08.002
基金项目: 

江苏省科技厅临床专项(BL2013004); 

详细信息
  • 中图分类号: R575

Clinical features and diagnosis of inherited metabolic liver disease

Research funding: 

 

  • 摘要: 遗传代谢性肝病病因复杂,种类多样,临床表现无特异性,诊断困难,容易漏诊、误诊,需结合患者症状、体征、实验室检查、影像学检查、肝穿刺病理、基因检测等做出正确的临床诊断,为早期治疗提供依据。因此,从临床中发现线索对于诊断该病有着重要的作用,现对遗传代谢性肝病的临床线索及临床诊断思路进行总结。

     

  • [1] ZHANG YN, XU Y, JIANG C, et al. Diagnosis and treatment of inherited metabolic liver disease[J]. J Clin Hepatol, 2019, 35 (4) :921-924. (in Chinese) 张亚南, 许影, 蒋畅, 等.遗传代谢性肝病的诊治[J].临床肝胆病杂志, 2019, 35 (4) :921-924.
    [2] KIM JS, KIM KM, OH SH, et al. Liver transplantation for metabolic liver disease:Experience at a living donor dominant liver transplantation center[J]. Pediatr Gastroenterol Hepatol Nutr, 2015, 18 (1) :48-54.
    [3] ONNERHAG K, DREJA K, NILSSON PM, et al. Increased mortality in non-alcoholic fatty liver disease with chronic kidney disease is explained by metabolic comorbidities[J]. Clin Res Hepatol Gastroenterol, 2019.[Epub ahead of print]
    [4] AHN AL, CHOI JK, KIM MN, et al. Non-alcoholic fatty liver disease and chronic kidney disease in Koreans aged 50 years or older[J]. Korean J Fam Med, 2013, 34 (3) :199-205.
    [5] TARGHER G, CHONCHOL M, ZOPPINI G, et al. Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease:Is there a link?[J]. J Hepatol, 2011, 54 (5) :1020-1029.
    [6] ALAM S, SOOD V. Metabolic liver disease:When to suspect and how to diagnose?[J]. Indian J Pediatr, 2016, 83 (11) :1321-1333.
    [7] ROY A, SAMANTA T, PURKAIT R, et al. Etiology, clinical spectrum and outcome of metabolic liver diseases in children[J]. J Coll Physicians Surg Pak, 2013, 23 (3) :194-198.
    [8] YAMAGUCHI K, WAKIMIZU R, KUBOTA M. Difficulties in daily life and associated factors, and qol of children with inherited metabolic disease and their parents in Japan:A literature review[J]. JIMD Rep, 2017, 33:1-10.
    [9] BRYSON TE, ANGLIN CM, BRIDGES PH, et al. Nucleasemediated gene therapies for inherited metabolic diseases of the liver[J]. Yale J Biol Med, 2017, 90 (4) :553-566.
    [10] KOSHY A, RAMASWAMY K, CORREA M, et al. Glycogen storage disease:Report of 17 cases from southern India[J].Indian J Gastroenterol, 2006, 25 (4) :182-184.
    [11] ZHANG ZH, LIN WX, DENG M, et al. Clinical, molecular and functional investigation on an infant with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) [J]. PLo S One, 2014, 9:e89267.
    [12] PANT M, OSHIMA K. Cholesteryl ester storage disease:An underdiagnosed cause of cirrhosis in adults[J]. Ann Diagn Pathol, 2017, 31:66-70.
    [13] NICOLAOU M, ANDRESS EJ, ZOLNERCIKS JK, et al. Canalicular ABC transporters and liver disease[J]. J Pathol, 2012, 226 (2) :300-315.
    [14] JOSHI D, GUPTA N, SAMYN M, et al. The management of childhood liver diseases in adulthood[J]. J Hepatol, 2017, 66 (3) :631-644.
    [15] YU H, XIE XB. Current perspectives on the etiology, diagnosis, and treatment of pediatric acute liver failure[J]. J ClinHepatol, 2012, 28 (12) :899-901. (in Chinese) 俞蕙, 谢新宝.儿童急性肝衰竭的病因及诊治[J].临床肝胆病杂志, 2012, 28 (12) :899-901.
    [16] DEVICTOR D, TISSIERES P, DURAND P, et al. Acute liver failure in neonates, infants and children[J]. Expert Rev Gastroenterol Hepatol, 2011, 5 (6) :717-729.
    [17] SQUIRES RJ, SHNEIDER BL, BUCUVALAS J, et al. Acute liver failure in children:The first 348 patients in the pediatric acute liver failure study group[J]. J Pediatr, 2006, 148 (5) :652-658.
    [18] DHAWAN A. Etiology and prognosis of acute liver failure in children[J]. Liver Transpl, 2008, 14 (Suppl 2) :s80-s84.
    [19] SATHE KP, NAGRAL A. Metabolic liver disease in developing world with special reference to Indian children-A review[J].Apollo Med, 2015, 12 (1) :22-31.
    [20] ARNON R, KERKAR N, DAVIS MK, et al. Liver transplantation in children with metabolic diseases:The studies of pediatric liver transplantation experience[J]. Pediatr Transplant, 2010, 14 (6) :796-805.
    [21] STEVENSON T, MILLAN MT, WAYMAN K, et al. Long-term outcome following pediatric liver transplantation for metabolic disorders[J]. Pediatric Transplant, 2010, 14 (2) :268-275.
    [22] LI D, LIN Y, HUANG Y, et al. Early prenatal diagnosis of lysosomal storage disorders by enzymatic and molecular analysis[J]. Prenat Diagn, 2018, 38 (3) :779-787.
    [23] SCHADY DA, FINEGOLD MJ. Contemporary evaluation of the pediatric liver biopsy[J]. Gastroenterol Clin North Am, 2017, 46 (2) :233-252.
    [24] YF Y. Atlas of liver pathology[M]. Changsha:Central-South University Publishing Group, 2018:52-75. (in Chinese) 杨永峰.肝脏病理学图解[M].长沙:中南大学出版社, 2018:52-75.
    [25] YANG YF, XIONG QF. Histopathological features and diagnostic consideration of genetic metabolic liver diseases[J].Chin J Hepatol, 2018, 26 (12) :885-888. (in Chinese) 杨永峰, 熊清芳.遗传代谢性肝病的组织病理学特征和诊断思路[J].中华肝脏病杂志, 2018, 26 (12) :885-888.
    [26] WASKOWICZ LR, ZHOU J, LANDAU DJ, et al. Bezafibrate induces autophagy and improves hepatic lipid metabolism in glycogen storage disease type Ia[J]. Hum Mol Genet, 2019, 28 (1) :143-154.
    [27] ADAMS DR, ENG CM. Next-generation sequencing to diagnose suspected genetic disorders[J]. N Engl J Med, 2019, 380 (2) :201.
    [28] NG SB, BUCKINGHAM KJ, LEE C, et al. Exome sequencing identifies the cause of a mendeliandisorder[J]. Nat Genet, 2010, 42 (1) :30-35.
    [29] TANG W, MAKUUCHI M. Intractable and rare diseases research[J]. Biosci Trends, 2012, 6 (2) :48-51.
  • 加载中
计量
  • 文章访问数:  1871
  • HTML全文浏览量:  43
  • PDF下载量:  568
  • 被引次数: 0
出版历程
  • 收稿日期:  2019-05-02
  • 出版日期:  2019-08-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回